LAVA Therapeutics N.V.
LAVA Therapeutics N.V. (LVTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LVTX · as of Jun 9, 2026
Key Statistics
Explore LAVA Therapeutics N.V. Data
lvtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
The LVTX analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $3.75, representing +115.52% upside from the current price of $1.74.
Competitors & Peers
lvtx competitorsLVTX
ATNM
CALC
CELU
ELUT
LTRNStock Performance
Full HistoryAbout LAVA Therapeutics N.V.
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the co…
what is lava therapeutics n.v. · lvtx stock overview · lava therapeutics n.v. company profile · who is lava therapeutics n.v. ceo · lvtx NASDAQ · lava therapeutics n.v. headquarters · lava therapeutics n.v. business segments
About Stock Overview & Key Data
LAVA Therapeutics N.V. (LVTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 26, 2021. As of the latest trading session, LVTX stock price is $1.74, with a market capitalization of $45.8M. The stock has returned +75.76% over the past 12 months and +68.93% year-to-date.
According to 6 Wall Street analysts, the consensus rating for LAVA Therapeutics N.V. stock is Hold, with an average 12-month price target of $3.75. In fiscal year 2024, LAVA Therapeutics N.V. reported revenue of $12.0M and net income of -$25.1M. For detailed data — including LAVA Therapeutics N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LAVA Therapeutics N.V. (LVTX) stock price is $1.74. The stock is traded on NASDAQ under the ticker symbol LVTX. The 52-week range is $0.85 – $2.00.